Breast cancer: A low-fat diet may improve survivors’ outlook
New research investigates whether following a low-fat diet after being diagnosed with breast cancer improves the patient’s outcome. …read more
Clinicians: Title X Proposal ‘Prohibits’ Discussion of Abortion
The Trump administration proposal would bar use of Title X funds in any facility that performs abortions. Medscape Medical News …read more
HHS Unveils Controversial Rule on Title X Abortion Restrictions
The Trump administration released its long-awaited ruling on title X funds and how they relate to abortion and family planning. Medscape Medical News …read more
FDA Approves Denosumab for Steroid-Induced Osteoporosis
The US FDA has approved denosumab (Prolia, Amgen) for treatment of glucocorticoid-induced osteoporosis. European regulators recently green-lighted the same indication. FDA Approvals …read more
Proposed Restrictions on Title X Funds Stirs Up Hornet’s Nest
Although a new Title X rule is yet to be officially released by the Trump administration, the topic has elicited strong reactions from groups on both sides of the abortion debate. Medscape Medical News …read more
DES Raises ADHD Risk in Grandchildren
Grandchildren of women who took diethylstilbestrol during pregnancy had a higher risk for ADHD compared with those whose grandmothers were not exposed to the drug in pregnancy. Medscape Medical News …read more
Very Obese Women: Lose Weight in Pregnancy for Healthy Baby
IOM 2009 recommendations are adequate for normal and overweight women but not the thin and obese, finds a study that explores optimal gestational weight gain for pregnant women of different maternal BMIs. Medscape Medical News …read more
Extreme Diets: Fads and Facts
Radical diets have exploded in popularity since the 19th century. We dig into notable examples — from Fletcherism to liquid diets to Beverly Hills — reviewing their history, claims, and impact. Medscape Internal Medicine …read more
US, EU Warn About Birth Defect Risk From Dolutegravir
The FDA and EMA have warned about a possible increased risk for neural tube defects in infants born to women who take dolutegravir for HIV during pregnancy. News Alerts …read more
Alendronate Reduces Cardiovascular Risk After Hip Fracture
Alendronate, and likely other bisphosphonates, lower cardiovascular event rates in patients treated for osteoporosis following a hip fracture. Medscape Medical News …read more